AWH: Aspira Women's Health Inc. Stock

by  •  • Comments Off on AWH: Aspira Women's Health Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 43.08
Enterprise Value ($M) 42.75
Book Value ($M) -2.37
Book Value / Share -0.19
Price / Book -18.22
NCAV ($M) -3.35
NCAV / Share -0.27
Price / NCAV -12.87

Profitability (mra)
Return on Invested Capital (ROIC) -34.27
Return on Assets (ROA) -1.45
Return on Equity (ROE) -20.18

Liquidity (mrq)
Quick Ratio 0.99
Current Ratio 1.03

Balance Sheet (mrq) ($M)
Current Assets 5.28
Assets 6.26
Liabilities 8.63
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9.15
Operating Income -18.85
Net Income -16.69
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Dilutive Effect Of Stock Options n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -15.89
Cash from Investing -0.02
Cash from Financing 5.22

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-08 13G/A Schultz Eric Adam 4.41 0.00
07-26 13D/A Schuler Jack W 18.70 -92.72

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K Delaware (State or Other Jurisdiction of Incorporation or Organization) 12117 Bee Caves Road, Building III, Suite 100 Austin, Texas (Address of Principal Executive Offices) DOCUMENTS INCORPORATED BY REFERENCE
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-10-26 10-K/A Delaware (State or Other Jurisdiction of Incorporation or Organization) 12117 Bee Caves Road, Building III, Suite 100 Austin, Texas (Address of Principal Executive Offices) DOCUMENTS INCORPORATED BY REFERENCE
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-22 140 5,238 2.67
2024-04-19 463 1,145 40.44
2024-04-18 1,171 1,502 77.96
2024-04-17 2,679 13,727 19.52

(click for more detail)

Similar Companies
ATOS – Atossa Therapeutics, Inc. ATXI – Avenue Therapeutics, Inc.
AVTX – Avalo Therapeutics, Inc. AYTU – Aytu BioPharma, Inc.
BCDA – BioCardia, Inc.


Financial data and stock pages provided by
Fintel.io